A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris
NCT02656485
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Acne Vulgaris
Interventions
DRUG:
B244
DRUG:
Placebo
Sponsor
AOBiome LLC